登陆
当前位置: 首页 >> 检索结果

结果排序

文献格式

出版时间

出版类型

出版语言
共有 8596 条符合本次的查询结果， 用时 4.9688994 秒

7201. Platelet-Rich Plasma Injection vs Sham Injection and Tendon Dysfunction in Patients With Chronic Midportion Achilles Tendinopathy.

作者: Gerard A Malanga.;Ken Mautner.;Don Buford.
来源: JAMA. 2021年326卷19期1974-1975页

7202. Platelet-Rich Plasma Injection vs Sham Injection and Tendon Dysfunction in Patients With Chronic Midportion Achilles Tendinopathy.

作者: Vincent Gremeaux.;Eric Noël.;Jean-Francois Kaux.
来源: JAMA. 2021年326卷19期1974页

7203. A Review of the Diagnosis and Treatment of Alcohol-Associated Liver Disease.

作者: Lanla Conteh.;Douglas Levin.
来源: JAMA. 2021年326卷19期1976页

7204. A Hospital and Postdischarge Quality Improvement Intervention and Outcomes and Care for Patients With Heart Failure With Reduced Ejection Fraction.

作者: Daniel S Kim.;Nhu Quyen Dau.;Harry Peled.
来源: JAMA. 2021年326卷19期1977页

7205. Platelet-Rich Plasma Injection vs Sham Injection and Tendon Dysfunction in Patients With Chronic Midportion Achilles Tendinopathy-Reply.

作者: Rebecca S Kearney.;Matthew L Costa.
来源: JAMA. 2021年326卷19期1975-1976页

7206. A Review of the Diagnosis and Treatment of Alcohol-Associated Liver Disease-Reply.

作者: Ashwani K Singal.;Philippe Mathurin.
来源: JAMA. 2021年326卷19期1976-1977页

7207. A Hospital and Postdischarge Quality Improvement Intervention and Outcomes and Care for Patients With Heart Failure With Reduced Ejection Fraction-Reply.

作者: Adam D DeVore.;Bradi Granger.;Adrian F Hernandez.
来源: JAMA. 2021年326卷19期1977-1978页

7208. Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction: The PARALLAX Randomized Clinical Trial.

作者: Burkert Pieske.;Rolf Wachter.;Sanjiv J Shah.;Abigail Baldridge.;Peter Szeczoedy.;Ghionul Ibram.;Victor Shi.;Ziqiang Zhao.;Martin R Cowie.; .
来源: JAMA. 2021年326卷19期1919-1929页
There is limited evidence on the benefits of sacubitril/valsartan vs broader renin angiotensin system inhibitor background therapy on surrogate outcome markers, 6-minute walk distance, and quality of life in patients with heart failure and mildly reduced or preserved left ventricular ejection fraction (LVEF >40%).

7209. Bell Palsy.

作者: Lanning B Kline.;Malcolm M Kates.;Mehdi Tavakoli.
来源: JAMA. 2021年326卷19期1983页

7210. What Makes Us Know We're Alive.

作者: Haley Newman.
来源: JAMA. 2021年326卷19期1911-1912页

7211. Global Plan Targets Elimination of Bacterial Meningitis Epidemics.

作者: Bridget M Kuehn.
来源: JAMA. 2021年326卷19期1898页

7212. WHO, Global Health Workers Demand Urgent Action on Climate Change.

作者: Bridget M Kuehn.
来源: JAMA. 2021年326卷19期1898页

7213. Lack of Adolescents' Mental Health Care Is a Global Challenge.

作者: Bridget M Kuehn.
来源: JAMA. 2021年326卷19期1898页

7214. Pharyngitis and Tonsillar Exudates in an 18-Year-Old Woman.

作者: Kristin Walter.
来源: JAMA. 2021年326卷21期2195-2196页

7215. Contextualizing Risk Among Patients With Heart Failure.

作者: Stephen J Greene.;Javed Butler.;Gregg C Fonarow.
来源: JAMA. 2021年326卷22期2261-2262页

7216. Strengthening the FDA's Enforcement of ClinicalTrials.gov Reporting Requirements.

作者: Reshma Ramachandran.;Christopher J Morten.;Joseph S Ross.
来源: JAMA. 2021年326卷21期2131-2132页

7217. Cervical Cancer Screening Guideline for Individuals at Average Risk.

作者: Julie Chor.;Andrew M Davis.;Jennifer M Rusiecki.
来源: JAMA. 2021年326卷21期2193-2194页

7218. Erroneous Terminology in Review.

来源: JAMA. 2021年326卷22期2333页

7219. Bariatric Surgery as a Strategy for Improving Outcomes in Nonalcoholic Steatohepatitis.

作者: Kathleen E Corey.;Zoe Nicole Memel.
来源: JAMA. 2021年326卷20期2015-2017页

7220. Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis.

作者: Ali Aminian.;Abbas Al-Kurd.;Rickesha Wilson.;James Bena.;Hana Fayazzadeh.;Tavankit Singh.;Vance L Albaugh.;Faiz U Shariff.;Noe A Rodriguez.;Jian Jin.;Stacy A Brethauer.;Srinivasan Dasarathy.;Naim Alkhouri.;Philip R Schauer.;Arthur J McCullough.;Steven E Nissen.
来源: JAMA. 2021年326卷20期2031-2042页
No therapy has been shown to reduce the risk of serious adverse outcomes in patients with nonalcoholic steatohepatitis (NASH).
共有 8596 条符合本次的查询结果， 用时 4.9688994 秒